Literature DB >> 10668482

Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis.

R Langenbach1, C D Loftin, C Lee, H Tiano.   

Abstract

Cyclooxygenase (COX)-1- and COX-2-deficient mice have unique physiological differences that have allowed investigation into the individual biological roles of the COX isoforms. In the following, the phenotypes of the two COX knockout mice are summarized, and recent studies to investigate the effects of COX deficiency on inflammatory responses and cancer susceptibility are discussed. The data suggest that both isoforms have important roles in the maintenance of physiological homeostasis and that such designations as house-keeping and/or response gene may not be entirely accurate. Furthermore, data from COX-deficient mice indicate that both isoforms can contribute to the inflammatory response and that both isoforms have significant roles in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668482     DOI: 10.1111/j.1749-6632.1999.tb08723.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  35 in total

Review 1.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Authors:  S L Tilley; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.

Authors:  Noriyuki Omura; Margaret Griffith; Audrey Vincent; Ang Li; Seung-Mo Hong; Kimberly Walter; Michael Borges; Michael Goggins
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

Review 3.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

4.  Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation.

Authors:  Yong I Cha; Seok-Hyung Kim; Diane Sepich; F Gregory Buchanan; Lilianna Solnica-Krezel; Raymond N DuBois
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

5.  Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Laurel L Ballantyne; Hu Meng; Garret A FitzGerald; Colin D Funk
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

6.  Reply to Hansen: Essentiality of n-3 fatty acids.

Authors:  William L Smith
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

7.  Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.

Authors:  C Iadecola; K Niwa; S Nogawa; X Zhao; M Nagayama; E Araki; S Morham; M E Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

8.  Development of a sensitive in vitro assay to quantify the biological activity of pro-inflammatory phorbol esters in Jatropha oil.

Authors:  Guillaume Pelletier; Bhaja K Padhi; Jalal Hawari; Geoffrey I Sunahara; Raymond Poon
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-01-15       Impact factor: 2.416

9.  Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9.

Authors:  Athira Omanakuttan; Jyotsna Nambiar; Rodney M Harris; Chinchu Bose; Nanjan Pandurangan; Rebu K Varghese; Geetha B Kumar; John A Tainer; Asoke Banerji; J Jefferson P Perry; Bipin G Nair
Journal:  Mol Pharmacol       Date:  2012-06-28       Impact factor: 4.436

10.  Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.

Authors:  Jun Yu; Alex Y Hui; Eagle S H Chu; Alfred S L Cheng; Minnie Y Y Go; Henry L Y Chan; Wai K Leung; Kin F Cheung; Arthur K K Ching; Yiu L Chui; Ka K Chan; Joseph J Y Sung
Journal:  Gut       Date:  2006-12-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.